| X23-10-ZQ354 |
Bcr-Abl inhibitor AT9283, Purity ≥98%
|
|
| X24-06-ZQ320 |
Bcr-Abl inhibitor 1-Naphthyl PP1 hydrochloride, Purity ≥98%
|
|
| X24-06-ZQ326 |
Bcr-Abl inhibitor AZD0424, Purity ≥98%
|
|
| X24-06-ZQ331 |
Bcr-Abl inhibitor BMS-354825, Purity ≥98%
|
|
| X24-06-ZQ342 |
Bcr-Abl inhibitor Lyn-IN-1, Purity ≥98%
|
|
| X24-06-ZQ350 |
Bcr-Abl inhibitor AZD0530, Purity ≥98%
|
|
| X24-06-ZQ365 |
Bcr-Abl inhibitor CHMFL-ABL/KIT-155, Purity ≥98%
|
|
| X24-06-ZQ367 |
Bcr-Abl inhibitor Dasatinib monohydrate, Purity ≥98%
|
|
| X24-06-ZQ416 |
Bcr-Abl inhibitor Asciminib, Purity ≥98%
|
|
| X24-06-ZQ419 |
Bcr-Abl inhibitor INNO-406, Purity ≥98%
|
|
| X24-06-ZQ423 |
Bcr-Abl inhibitor BCR-ABL-IN-1, Purity ≥98%
|
|
| X24-06-ZQ424 |
Bcr-Abl inhibitor BCR-ABL-IN-2, Purity ≥98%
|
|
| X24-06-ZQ437 |
Bcr-Abl inhibitor CHMFL-ABL-039, Purity ≥98%
|
|
| X24-06-ZQ438 |
Bcr-Abl inhibitor CHMFL-ABL-121, Purity ≥98%
|
|
| X24-06-ZQ441 |
Bcr-Abl inhibitor CT-721, Purity ≥98%
|
|
| X24-06-ZQ442 |
Bcr-Abl inhibitor CZC-8004, Purity ≥98%
|
|
| X24-06-ZQ444 |
Bcr-Abl inhibitor DCC-2036, Purity ≥98%
|
|
| X24-06-ZQ447 |
Bcr-Abl inhibitor DPH, Purity ≥98%
|
|
| X24-06-ZQ460 |
Bcr-Abl inhibitor GNF 2, Purity ≥98%
|
|
| X24-06-ZQ461 |
Bcr-Abl inhibitor GNF 5, Purity ≥98%
|
|
| X24-06-ZQ462 |
Bcr-Abl inhibitor GNF 7, Purity ≥98%
|
|
| X24-06-ZQ466 |
Bcr-Abl inhibitor GZD824, Purity ≥98%
|
|
| X24-06-ZQ467 |
Bcr-Abl inhibitor GZD824 dimesylate, Purity ≥98%
|
|
| X24-06-ZQ483 |
Bcr-Abl inhibitor AMN-107, Purity ≥98%
|
|
| X24-06-ZQ484 |
Bcr-Abl inhibitor Nilotinib monohydrochloride monohydrate, Purity ≥98%
|
|
| X24-06-ZQ486 |
Bcr-Abl inhibitor NRC-AN-019, Purity ≥98%
|
|
| X24-06-ZQ497 |
Bcr-Abl inhibitor PD173955, Purity ≥98%
|
|
| X24-06-ZQ522 |
Bcr-Abl inhibitor Radotinib, Purity ≥98%
|
|
| X24-06-ZQ527 |
Bcr-Abl inhibitor SNIPER(ABL)-062, Purity ≥98%
|
|
| X24-06-ZQ536 |
Bcr-Abl inhibitor Vodobatinib, Purity ≥98%
|
|
| X24-06-ZQ537 |
Bcr-Abl inhibitor WP1130, Purity ≥98%
|
|
